Emurmur
Emurmu, a healthcare technology company, specializes in developing innovative mobile and web applications aimed at improving patient care and operational efficiency. With a primary focus on safeguarding adherence to FDA regulations, Emurmu sought to secure its applications against potential vulnerabilities while maintaining compliance standards.
The company required a security audit and penetration test to ensure their applications met stringent FDA compliance requirements.
Emurmu requested a deep dive into potential vulnerabilities in both their mobile and web applications.
Emurmu needed a detailed penetration testing report and a Letter of Attestation to assure stakeholders and clients of their platform's security.
Qualysec’s team approached the project with a combination of manual and automated testing methods. We identified and addressed vulnerabilities across Emurmu’s mobile and web platforms through Compliance-Driven Testing, In-Depth Assessment, and Detailed Reporting. Upon completing the tests, we provided a Letter of Attestation (LoA) and security certification.
Emurmu successfully met FDA compliance requirements.
Both mobile and web applications were secured against potential threats.
Emurmu’s robust security and FDA compliance became a significant differentiator in the healthcare market.
The team demonstrated exceptional professionalism with their consistently short response times and strict adherence to the project schedule. Their professionalism was impressive.
Andreas Schriefl
Founder and CEO
Get a Quote
Now is the perfect time to stay one step ahead of evolving cyber threats by taking proactive security measures. Fill out the form, and our expert pentesters will help you identify and address vulnerabilities before they escalate.
Total No. Of Vulnerabilities
Years in Business
Assessment Completed
Trusted Clients
Countries Served
